MML Investors Services LLC grew its position in Masimo Co. (NASDAQ:MASI) by 48.6% during the first quarter, HoldingsChannel.com reports. The firm owned 9,513 shares of the medical equipment provider’s stock after buying an additional 3,112 shares during the quarter. MML Investors Services LLC’s holdings in Masimo were worth $1,315,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc increased its position in Masimo by 2.7% during the third quarter. Vanguard Group Inc now owns 4,147,708 shares of the medical equipment provider’s stock worth $516,556,000 after acquiring an additional 109,065 shares during the period. FMR LLC increased its position in Masimo by 17.8% during the fourth quarter. FMR LLC now owns 3,889,562 shares of the medical equipment provider’s stock worth $417,622,000 after acquiring an additional 587,587 shares during the period. MERIAN GLOBAL INVESTORS UK Ltd increased its position in Masimo by 12.6% during the fourth quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 779,500 shares of the medical equipment provider’s stock worth $83,694,000 after acquiring an additional 87,476 shares during the period. Victory Capital Management Inc. increased its position in Masimo by 13.3% during the fourth quarter. Victory Capital Management Inc. now owns 726,329 shares of the medical equipment provider’s stock worth $77,986,000 after acquiring an additional 85,255 shares during the period. Finally, Janus Henderson Group PLC increased its position in Masimo by 11.7% during the first quarter. Janus Henderson Group PLC now owns 590,599 shares of the medical equipment provider’s stock worth $81,668,000 after acquiring an additional 61,762 shares during the period. 83.66% of the stock is currently owned by institutional investors.

A number of research firms have weighed in on MASI. UBS Group lifted their price target on shares of Masimo from $147.00 to $160.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. Piper Jaffray Companies lifted their price target on shares of Masimo from $148.00 to $160.00 in a research note on Friday, May 17th. Stifel Nicolaus lifted their price target on shares of Masimo from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Friday, May 17th. Needham & Company LLC reiterated a “buy” rating and set a $158.00 price target (up previously from $155.00) on shares of Masimo in a research note on Tuesday, May 7th. Finally, Zacks Investment Research upgraded shares of Masimo from a “hold” rating to a “buy” rating and set a $153.00 price target on the stock in a research note on Wednesday, May 8th. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $154.25.

MASI traded up $1.64 during trading on Wednesday, reaching $142.96. 3,071 shares of the company’s stock were exchanged, compared to its average volume of 452,808. Masimo Co. has a fifty-two week low of $96.14 and a fifty-two week high of $147.91. The company has a market capitalization of $7.64 billion, a P/E ratio of 47.18, a P/E/G ratio of 2.75 and a beta of 1.09.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Monday, May 6th. The medical equipment provider reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.75 by $0.04. Masimo had a net margin of 22.49% and a return on equity of 18.61%. The firm had revenue of $231.70 million for the quarter, compared to the consensus estimate of $223.67 million. During the same quarter in the previous year, the company earned $0.75 earnings per share. The business’s revenue was up 8.8% compared to the same quarter last year. On average, analysts forecast that Masimo Co. will post 3.12 earnings per share for the current fiscal year.

In other news, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $135.00, for a total value of $1,350,000.00. Following the sale, the director now owns 74,832 shares in the company, valued at approximately $10,102,320. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Ramshorst David J. Van sold 1,845 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $140.00, for a total transaction of $258,300.00. Following the completion of the sale, the chief accounting officer now owns 1,695 shares in the company, valued at approximately $237,300. The disclosure for this sale can be found here. Insiders sold a total of 55,695 shares of company stock worth $7,756,550 in the last 90 days. 11.50% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.watchlistnews.com/masimo-co-nasdaqmasi-stake-boosted-by-mml-investors-services-llc/3039326.html.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Read More: Short Selling Stocks, A Beginner’s Guide

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.